GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that the Company’s management will be attending and presenting at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place December 3-4, 2024, in Boca Raton, Florida.
Las Vegas, CA, April 19, 2025 (GLOBE NEWSWIRE) -- Online real money casinos are hard…
A new study predicts that Bitcoin could hit $1 million as early as 2027 as…
In a notable shift in market dynamics, the latest data from the Commodity Futures Trading…
In a notable development for the agricultural commodities market, the U.S. Commodity Futures Trading Commission…
In the latest market activity, speculative positions in the New Zealand Dollar (NZD) have shown…
In a recent update from the Commodity Futures Trading Commission (CFTC), the Japanese Yen (JPY)…
This website uses cookies.